Thymic carcinomas (29 of 47; 62%) had a higher incidence of somatic non-synonymous mutations than thymomas (4 of 31; 13%; p < 0.0001) and TP53 was the most frequently mutated gene (17%), especially in thymic carcinomas (26%). This evidence concerns the gene TP53 and thymic carcinoma.